Physician profile
Kan Yu
NPI 1437372521
$35,245.33
in general payments reported to CMS, 2019-2025
96 companies · $4,957 in 2025
The $4,957 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,591 · 2020: $3,973 · 2021: $4,428 · 2022: $5,768 · 2023: $6,668 · 2024: $4,860 · 2025: $4,957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,018.08 |
| Education | $467.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,106.11 | 2020-2025 | Ubrelvy, Qulipta, Botox |
| Biogen, INC. | $2,393.38 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Ucb, INC. | $2,242.42 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Novartis Pharmaceuticals Corporation | $2,130.88 | 2019-2025 | |
| Allergan, INC. | $1,610.44 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $1,587.98 | 2019-2025 | Austedo Xr, Austedo Xr |
| Genzyme Corporation | $1,374.86 | 2019-2025 | |
| Emd Serono, INC. | $1,362.82 | 2019-2025 | Mavenclad |
| Lilly USA, LLC | $1,088.69 | 2019-2025 | Emgality, Kisunla, Reyvow |
| Lundbeck LLC | $952.49 | 2019-2025 | Vyepti, Rexulti |
| Neurocrine Biosciences, INC. | $894.90 | 2020-2025 | Ingrezza, Ongentys |
| Harmony Biosciences LLC | $850.55 | 2020-2025 | Wakix |
| Genentech USA, INC. | $806.49 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Eisai INC. | $795.60 | 2019-2025 | |
| Amgen INC. | $718.27 | 2019-2023 | Aimovig |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $693.13 | 2020-2025 | |
| Upsher-Smith Laboratories LLC | $671.25 | 2019-2023 | |
| Amneal Pharmaceuticals LLC | $647.02 | 2019-2025 | Rytary, Crexont, Lyvispah |
| Sk Life Science, INC. | $629.25 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $626.99 | 2019-2022 | |
| Celgene Corporation | $558.38 | 2020-2025 | Zeposia |
| Biohaven Pharmaceuticals, INC. | $556.79 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $513.82 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $468.17 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $439.13 | 2022 | |
| Alexion Pharmaceuticals, INC. | $391.77 | 2019-2025 | Ultomiris |
| Impel Pharmaceuticals INC. | $362.13 | 2022-2023 | Trudhesa |
| Axsome Therapeutics, INC. | $358.37 | 2025 | Symbravo |
| Argenx US, INC. | $342.23 | 2022-2025 | Vyvgart Hytrulo |
| Vanda Pharmaceuticals INC. | $333.18 | 2024-2025 | Ponvory, Fanapt |
| E.R. Squibb & Sons, L.L.C. | $302.93 | 2020-2022 | |
| Neurelis, INC. | $296.45 | 2020-2025 | Valtoco |
| Idorsia Pharmaceuticals US INC | $271.83 | 2022-2024 | Quviviq |
| Sumitomo Pharma America, INC. | $251.81 | 2023-2024 | Aptiom |
| Boston Scientific Corporation | $232.61 | 2020-2025 | Watchman Access System, Superion Indirect Decompression System, Watchman Flx |
| Assertio Therapeutics, INC. | $216.46 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $197.80 | 2023-2025 | Rexulti, Nuedexta |
| Scilex Pharmaceuticals INC. | $191.81 | 2019-2024 | Ztlido |
| Zyla Life Sciences, INC. | $189.03 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $185.34 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $184.67 | 2022-2024 | Amvuttra, Givlaari |
| Kyowa Kirin, INC. | $182.14 | 2022-2024 | Nourianz |
| Tg Therapeutics, INC. | $160.68 | 2023 | |
| Tanabe Pharma America, INC. | $150.98 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $137.22 | 2021-2024 | Acthar |
| Banner Life Sciences, LLC | $125.99 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $120.16 | 2021-2025 | Wainua, Evusheld |
| Bausch Health US, LLC | $117.45 | 2019 | |
| Jazz Pharmaceuticals INC. | $108.58 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $105.73 | 2020-2022 | |
| Ge Healthcare | $105.49 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $104.39 | 2020-2023 | Belsomra |
| Corium, LLC | $103.17 | 2022-2023 | Adlarity |
| Merz Pharmaceuticals, LLC | $102.77 | 2021-2022 | |
| Merz North America, INC. | $99.94 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $95.14 | 2020-2023 | Onzetra Xsail |
| Csl Behring | $71.06 | 2022-2023 | Hizentra, Privigen |
| Grifols USA, LLC | $66.20 | 2019-2024 | Gamunex-C |
| Acadia Pharmaceuticals INC | $62.63 | 2022-2025 | Nuplazid |
| Medtronic, INC. | $60.35 | 2023-2025 | Intellis Adaptivestim, Reveal Linq, Percept Pc Brainsense |
| Novo Nordisk INC | $58.09 | 2024-2025 | Wegovy |
| Impel Pharmaceuticals LLC | $53.46 | 2024-2025 | Trudhesa |
| Vertical Pharmaceuticals, LLC | $51.45 | 2019 | |
| Cycle Pharmaceuticals INC | $48.49 | 2025 | Tascenso Odt, Bafiertam |
| Azurity Pharmaceuticals, INC. | $48.14 | 2023-2024 | Horizant, Horizant |
| Abbott Laboratories | $44.45 | 2023-2024 | Proclaim |
| Sandoz INC. | $43.84 | 2025 | Tyruko |
| Nevro Corp. | $39.99 | 2020-2021 | |
| Octapharma USA, INC. | $39.89 | 2023-2024 | Panzyga |
| Tonix Medicines, INC. | $39.72 | 2024-2025 | Zembrace Symtouch |
| Philips North America LLC | $37.53 | 2020 | |
| Tersera Therapeutics LLC | $36.92 | 2024 | Quzyttir |
| Aprecia Pharmaceuticals, LLC | $36.19 | 2022-2023 | Spritam |
| Ironwood Pharmaceuticals, INC | $36.08 | 2020 | |
| Mdd US Operations, LLC | $35.83 | 2019-2025 | Apokyn |
| Horizon Therapeutics Plc | $34.37 | 2022-2023 | Uplizna |
| Averitas Pharma INC. | $34.32 | 2025 | Qutenza |
| Livanova USA, INC. | $34.02 | 2019-2021 | |
| Edw Pharma, INC. | $33.79 | 2023 | Tiglutik |
| Bardy Diagnostics, INC. | $32.17 | 2022 | |
| Promius Pharma LLC | $28.31 | 2019 | |
| Biotronik INC. | $26.82 | 2025 | Amvia Edge |
| Acorda Therapeutics, INC | $25.22 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $24.17 | 2023 | Firdapse |
| Otto Bock Healthcare Lp | $23.84 | 2023 | |
| Janssen Biotech, INC. | $22.75 | 2025 | |
| Zoll Respicardia, INC. | $22.74 | 2023 | Remede System |
| Saluda Medical Americas, INC. | $22.15 | 2024 | Evoke |
| C2n Diagnostics, LLC | $21.79 | 2025 | Precivityad2 |
| Grt US Holding, INC. | $19.21 | 2019 | |
| Metacel Pharmaceuticals LLC | $15.58 | 2025 | Ozobax |
| Noctrix Health, INC. | $15.34 | 2025 | Nidra |
| Arbor Pharmaceuticals, INC. | $13.61 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.31 | 2023 | Keveyis |
| Collegium Pharmaceutical, INC. | $12.34 | 2022 | |
| Mallinckrodt Enterprises LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kan Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.